Top Markets
Coin of the day
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Classement en actions #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Prix de l'action
$3.78
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$71.20M
Changement (1 jour)
2.24%
Changement (1 an)
-43.37%
Pays
FR
Échange MaaT Pharma S.A. (MAAT)

Catégorie

Historique du prix de l'action pour MaaT Pharma S.A. (MAAT)
Prix de clôture le plus élevé : $3.53 le 2026-08-01

Prix de clôture le plus bas : $15.22 le 2021-11-01
Historique du prix de l'action de MaaT Pharma S.A. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 10.63%
2025 -39.72%
2024 11.45%
2023 -18.97%
2022 -38.00%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH